Glycogen synthase kinase 3: an emerging therapeutic target
- 1 March 2002
- journal article
- review article
- Published by Elsevier in Trends in Molecular Medicine
- Vol. 8 (3), 126-132
- https://doi.org/10.1016/s1471-4914(01)02266-3
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Glycogen Synthase Kinase 3β Is Tyrosine Phosphorylated by PYK2Biochemical and Biophysical Research Communications, 2001
- Activation of glycogen synthase kinase 3 beta (GSK‐3β) by platelet activating factor mediates migration and cell death in cerebellar granule neuronsEuropean Journal of Neuroscience, 2001
- Piecing Together Alzheimer'sScientific American, 2000
- The pathogenic L392V mutation of presenilin 1 decreases the affinity to glycogen synthase kinase-3βNeuroscience Letters, 2000
- Glycogen synthase kinase-3β, β-catenin, and tau in postmortem bipolar brainJournal of Neural Transmission, 1999
- Direct association of presenilin‐1 with β‐cateninFEBS Letters, 1998
- Heat stress induces tyrosine phosphorylation/activation of kinase Fa/GSK-3α (a human carcinoma dedifferentiation modulator) in A431 cellsJournal of Cellular Biochemistry, 1997
- Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cellsCurrent Biology, 1996
- Glycogen synthase kinase‐3 and the Alzheimer‐like state of microtubule‐associated protein tauFEBS Letters, 1992
- Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinaseNeuroscience Letters, 1992